Mark Hite

1.5k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Mark Hite is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Cancer Research. According to data from OpenAlex, Mark Hite has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Health, Toxicology and Mutagenesis and 5 papers in Cancer Research. Recurrent topics in Mark Hite's work include Carcinogens and Genotoxicity Assessment (5 papers), Effects and risks of endocrine disrupting chemicals (3 papers) and Chemical Safety and Risk Management (3 papers). Mark Hite is often cited by papers focused on Carcinogens and Genotoxicity Assessment (5 papers), Effects and risks of endocrine disrupting chemicals (3 papers) and Chemical Safety and Risk Management (3 papers). Mark Hite collaborates with scholars based in United States, Canada and Sweden. Mark Hite's co-authors include John A. Heddle, James T. MacGregor, Michael F. Salamone, Kathleen H. Mavournin, Gordon W. Newell, Barry H. Margolin, Raymond R. Tice, D. Wild, Helen R. Skeggs and Susan M. Thornton and has published in prestigious journals such as Journal of Medicinal Chemistry, Toxicology and Applied Pharmacology and Electrophoresis.

In The Last Decade

Mark Hite

20 papers receiving 1.1k citations

Hit Papers

The induction of micronuclei as a measure of genotoxicity 1983 2026 1997 2011 1983 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Hite United States 10 692 396 379 278 85 20 1.2k
Kathleen H. Mavournin United States 8 838 1.2× 420 1.1× 473 1.2× 340 1.2× 72 0.8× 10 1.3k
Naonori Matsusaka Japan 20 474 0.7× 455 1.1× 327 0.9× 226 0.8× 83 1.0× 87 1.2k
Motoi Ishidate Japan 11 886 1.3× 425 1.1× 566 1.5× 396 1.4× 124 1.5× 28 1.5k
E. Longstaff United Kingdom 13 492 0.7× 299 0.8× 267 0.7× 163 0.6× 67 0.8× 34 875
Richard H.C. San United States 26 1.0k 1.5× 459 1.2× 850 2.2× 369 1.3× 75 0.9× 53 1.9k
B. Myhr United States 24 1.0k 1.5× 371 0.9× 777 2.1× 409 1.5× 82 1.0× 45 1.6k
R. Valencia United States 17 658 1.0× 342 0.9× 419 1.1× 432 1.6× 70 0.8× 30 1.1k
W.J. Muriel United Kingdom 16 612 0.9× 200 0.5× 758 2.0× 257 0.9× 103 1.2× 19 1.3k
N J van Sittert Netherlands 19 713 1.0× 622 1.6× 196 0.5× 204 0.7× 76 0.9× 34 1.2k
A.F. McFee United States 17 775 1.1× 238 0.6× 529 1.4× 431 1.6× 96 1.1× 50 1.5k

Countries citing papers authored by Mark Hite

Since Specialization
Citations

This map shows the geographic impact of Mark Hite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hite more than expected).

Fields of papers citing papers by Mark Hite

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hite. The network helps show where Mark Hite may publish in the future.

Co-authorship network of co-authors of Mark Hite

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hite. A scholar is included among the top collaborators of Mark Hite based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hite. Mark Hite is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dagenais, Simon, et al.. (2009). Acute Toxicity Evaluation of Proliferol: A Dose-Escalating, Placebo-Controlled Study in Swine. International Journal of Toxicology. 28(3). 219–229. 2 indexed citations
2.
Dagenais, Simon, et al.. (2007). Acute Toxicity Evaluation of Proliferol: A Dose-Escalating, Placebo-Controlled Study in Rats. International Journal of Toxicology. 26(5). 451–463. 5 indexed citations
3.
Turner, Scott, Christian Fédérici, Mark Hite, & Reza Fassihi. (2004). Formulation Development and Human In Vitro‐In Vivo Correlation for a Novel, Monolithic Controlled‐Release Matrix System of High Load and Highly Water‐Soluble Drug Niacin. Drug Development and Industrial Pharmacy. 30(8). 797–807. 41 indexed citations
4.
Hite, Mark. (1997). Safety Pharmacology Approaches. International Journal of Toxicology. 16(1). 23–31. 1 indexed citations
6.
Leeson, Mark C. & Mark Hite. (1989). Ganglioneuroma of the sacrum.. PubMed. 102–5. 16 indexed citations
7.
MacGregor, James T., John A. Heddle, Mark Hite, et al.. (1987). Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes. Mutation Research/Genetic Toxicology. 189(2). 103–112. 326 indexed citations
8.
MUSSER, JOHN H., Dennis Kubrak, Joseph Chang, et al.. (1987). Leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Synthesis of benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid esters. Journal of Medicinal Chemistry. 30(2). 400–405. 18 indexed citations
9.
Sargent, Edward V., et al.. (1986). Hazard Evaluation of Monochloroacetone. American Industrial Hygiene Association Journal. 47(7). 375–378. 1 indexed citations
10.
Sargent, Edward V., et al.. (1986). Hazard Evaluation of Monochloroacetone. American Industrial Hygiene Association Journal. 47(7). 375–378. 4 indexed citations
11.
Heddle, John A., Mark Hite, Kathleen H. Mavournin, et al.. (1983). The induction of micronuclei as a measure of genotoxicity. Mutation Research/Reviews in Genetic Toxicology. 123(1). 61–118. 641 indexed citations breakdown →
12.
Diamond, Leila, et al.. (1982). The effect of liver homogenate (S20) concentration on polycyclic aromatic hydrocarbon activation and mutation induction in the L5178Y mouse lymphoma mutation assay. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 106(1). 101–112. 3 indexed citations
13.
Hite, Mark, et al.. (1980). The effect of benzene in the micronucleus test. Mutation Research/Genetic Toxicology. 77(2). 149–155. 46 indexed citations
14.
Hite, Mark, William E. Rinehart, William A. Braun, & Harold M. Peck. (1979). Acute toxicity of methyl fluorosulfonate (Magic Methyl). American Industrial Hygiene Association Journal. 40(7). 600–603. 8 indexed citations
15.
Hite, Mark & Helen R. Skeggs. (1979). Mutagenic evaluation of nitroparaffins in the salmonella typhimurium/mammalian‐microsome test and the micronucleus test. Environmental Mutagenesis. 1(4). 383–389. 30 indexed citations
16.
Hite, Mark, et al.. (1977). The effect of cyproheptadine on the chromosomes of human lymphocytes in vitro.. PubMed. 27(6). 1203–6. 5 indexed citations
17.
Hite, Mark, et al.. (1976). Mutagenic evaluation of ronidazole. Mutation Research/Genetic Toxicology. 40(4). 289–304. 13 indexed citations
18.
Brown, W. Ray, et al.. (1974). Preclinical toxicological studies of carbidopa and combinations of carbidopa and levodopa. Toxicology and Applied Pharmacology. 29(2). 181–195. 6 indexed citations
19.
Brown, William R., et al.. (1972). Experimental papilledema in the dog induced by a salicylanilide. Toxicology and Applied Pharmacology. 21(4). 532–541. 10 indexed citations
20.
Fairchild, Edward J., et al.. (1964). Changes in thyroid I131 activity in ozone-tolerant and ozone-susceptible rats. Toxicology and Applied Pharmacology. 6(5). 607–613. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026